Danielle Brianne Chaplin, ARNP

Danielle Chaplin practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Danielle Chaplin's NPI, 1689081689, was assigned on July 22, 2014. Danielle Chaplin holds Florida license ARNP9310509.

Danielle Chaplin's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Danielle Chaplin's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians. Dmand AI also links Danielle Chaplin to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Danielle Chaplin practices, 3 sites in all. Vendor and product names are available with a free account.

Family medicine is Danielle Chaplin's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Danielle Chaplin is licensed in Florida.

Dmand AI lists acne, acute sinusitis, acute skin infection, bronchitis, chronic nasal allergies, conjunctivitis, contact dermatitis and fluid and electrolyte imbalances among the conditions Danielle Chaplin treats.

CMS data shows 103 Medicare services from Danielle Chaplin across 3 procedure codes in 2024, for 60 Medicare patients. Medicare paid $4,873 for them. Every service was in an office.

CMS counts 60 Medicare patients who saw Danielle Chaplin in 2024. The largest group is 75 to 84, with 25 patients. 75% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Danielle Chaplin's median patient age at 69, with 78% women.

In 2024, Danielle Chaplin wrote 224 Medicare Part D claims for 63 patients. 92% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $6,947 in total drug cost. In 2023, CMS named 272 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Danielle Chaplin for performance year 2024, reported through an alternative payment model (APM). CMS lists Danielle Chaplin as offering telehealth.

CMS Open Payments shows 1 general payment to Danielle Chaplin from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $103.